1. Cancer Research UK. Skin cancer statistics. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/skin-cancer. [Accessed August 2, 2016].
2. National Institute for Health and Care Excellence. Nivolumab for treating advanced (unresectable or metastatic) melanoma: evidence—cost-effectiveness. Available from: https://www.nice.org.uk/guidance/ta384/chapter/3-Evidence#cost-effectiveness. [Accessed October 2, 2017].
3. UK National Screening Committee. Current UK NSC recommendations. Available from: http://legacy.screening.nhs.uk/screening-recommendations.php?sortby=R_LastReview_date&direction=ASC. [Accessed August 2, 2016].
4. Feasibility of targeted early detection for melanoma: a population-based screening study;Melia;Br J Cancer,2000
5. Cancer Research UK. Skin cancer screening. Available from: http://www.cancerresearchuk.org/about-cancer/type/skin-cancer/about/skin-cancer-screening. [Accessed August 2, 2016].